Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.
about
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialPrediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma.Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.
P2860
Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduction of serum IGF-I level ...... VEGF and K-ras gene mutation.
@en
Reduction of serum IGF-I level ...... VEGF and K-ras gene mutation.
@nl
type
label
Reduction of serum IGF-I level ...... VEGF and K-ras gene mutation.
@en
Reduction of serum IGF-I level ...... VEGF and K-ras gene mutation.
@nl
prefLabel
Reduction of serum IGF-I level ...... VEGF and K-ras gene mutation.
@en
Reduction of serum IGF-I level ...... VEGF and K-ras gene mutation.
@nl
P2093
P2860
P50
P356
P1476
Reduction of serum IGF-I level ...... VEGF and K-ras gene mutation.
@en
P2093
Claudia Greco
Francesco Pisani
Franco Ameglio
Gaetano Vitelli
Giuseppe Vercillo
Maria Concetta Petti
P2860
P2888
P356
10.1186/1756-9966-28-35
P577
2009-03-10T00:00:00Z
P5875
P6179
1020705902